Affymax: Hematide comparable to Epogen in trial - Reuters PDF Print
ReutersT) said early results from a mid-stage trial showed that their once-weekly drug Hematide increased hemoglobin levels in anemic kidney dialysis patients as

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.